Cell therapies often involve introduction of genetically transformed cells into a patient. Recently there has been renewed interest in non-viral gene modification for this application as an alternative to lentiviral vectors.

This exclusive Q&A event invites you to ask anything about the world of predatory conferences to our expert speaker.

In this webinar, Scalable production of AAV from shake flasks to 1,000 L single use bioreactors using the Gibco™ CTS™ AAV‑MAX Production System, Jon Zmuda from Thermo Fisher Scientific will share several case studies

This talk delves into the fascinating world of aptamers. Aptamers are short single-stranded nucleic acid oligomers, either DNA or RNA, known for their ability to form intricate three-dimensional structures. The development of aptamers relies on SELEX (systematic evolution of ligands by exponential enrichment), a process that allows researchers to fine-tune their characteristics during selection.

This one-day online event will feature short talks covering recent innovations in research and technology in the cell and gene therapy domain. Our expert panel of presenters will address key advances across the entire R&D pipeline, from pre-clinical work right through to bioprocessing and manufacturing.

An incredible opportunity to ask the Chief Editor of Nature on how to get published in high-ranking journals.